South Plains Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Buy
6,504
+30
+0.5% +$6.66K 0.82% 35
2025
Q4
$1.48M Buy
6,474
+257
+4% +$58.5K 0.88% 29
2025
Q3
$1.44M Buy
6,217
+372
+6% +$75.8K 0.9% 28
2025
Q2
$1.08M Buy
5,845
+205
+4% +$38.1K 0.76% 37
2025
Q1
$1.18M Buy
5,640
+294
+5% +$57.2K 0.92% 32
2024
Q4
$950K Buy
+5,346
New +$983K 0.73% 41

Other funds holding ABBV

South Plains Financial's ABBV Position: Q1 2026 in Review

South Plains Financial increased its AbbVie (ABBV) stake by 0.46% in Q1 2026, buying an estimated $6.66K and bringing the position to 6,504 shares worth $1.41M. The position accounts for 0.82% of the portfolio, ranked #35.

South Plains Financial first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.48M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • South Plains Financial held 6,504 shares of AbbVie worth $1.41M as of Q1 2026.
  • South Plains Financial bought 30 AbbVie shares in Q1 2026, an estimated $6.66K.
  • AbbVie made up 0.82% of South Plains Financial's portfolio in Q1 2026, its #35 holding.
  • South Plains Financial first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • South Plains Financial's AbbVie position peaked at $1.48M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on South Plains Financial's 13F filing for Q1 2026, filed 13 May 2026.